RBC Capital Maintains Sector Perform on Inovio Pharmaceuticals, Lowers Price Target to $8
RBC Capital Maintains Sector Perform on Inovio Pharmaceuticals, Lowers Price Target to $8
RBC Capital維持伊諾維奧製藥板塊表現評級，將目標股價下調至8美元。
RBC Capital analyst Gregory Renza maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and lowers the price target from $11 to $8.
RBC資本分析師Gregory Renza維持了Inovio Pharmaceuticals (納斯達克股票代碼：INO)的板塊表現評級，將價格目標從11美元降至8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。